SUNSHINE BIOPHARMA, INC
Profile
Company Names
SUNSHINE BIOPHARMA, INC
Addresses
6500 TRANS-CANADA HIGHWAY, 4TH FLOOR, POINTE-CLAIRE, A8 H9R 0A5
6500 TRANS-CANADA HIGHWAY, 4TH FLOOR, POINTE-CLAIRE, A8 H9R 0A5
469 JEAN-TALON WEST, 3RD FLOOR, MONTREAL, A8 H3N 1R4
Phone Numbers
514-426-6161
(514) 426-6161
514-764-9698
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
COLORADO
Total Amount Raised:
$32,952,127.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-05-12
$4,996,497.00
$4,996,497.00
$0.00
Equity
3
2022-04-25
$19,497,618.00
$19,497,618.00
$0.00
Equity
2
2022-03-10
$7,998,699.00
$7,998,699.00
$0.00
Equity
1
2012-07-13
$459,313.00
$5,000,000.00
$4,540,687.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDREW
KELLER
DIRECTOR
FORT GLOBAL DIVERSIFIED LP
| FORT GLOBAL CONTRARIAN LP
| FORT VALUE MARKET NEUTRAL, LP
| FORT GLOBAL FUTURES, L.P.
| FORT GLOBAL LONG/SHORT, L.P.
| FORT EQUITY MARKET NEUTRAL, LP
| CLASS C SEGREGATED PORTFOLIO OF FORT GLOBAL OFFSHORE FUND, SPC
| CLASS D SEGREGATED PORTFOLIO OF FORT GLOBAL OFFSHORE FUND, SPC
| CLASS F SEGREGATED PORTFOLIO OF FORT GLOBAL OFFSHORE FUND, SPC
| FORT GLOBAL TREND FUND SERIES A 2020, L.P.
| CLASS T SEGREGATED PORTFOLIO OF FORT GLOBAL OFFSHORE FUND, SPC
| SUNSHINE BIOPHARMA, INC
DAVID
NATAN
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-05-12
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Equity
2022-04-25
D
PHARMACEUTICALS
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Equity
2022-03-10
D
PHARMACEUTICALS
SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
DECLINE TO DISCLOSE
Equity
2012-07-13
